Enhanced and Comprehensive: HUABAO Fund's HK Stock Connect Innovative Drug ETF Rebalances, Swiftly Includes Newly Eligible Stocks for Full Coverage of 50 R&D Firms

Deep News
Mar 12

The HUABAO HANG SENG HONG KONG STOCK CONNECT INNOVATIVE DRUG SELECTION TRADING OPEN ENDED INDEX SECURITIES INVESTMENT FUND has executed a portfolio rebalancing. The adjustment promptly incorporates newly eligible stocks under the Hong Kong Stock Connect scheme, achieving extensive coverage of 50 innovative drug research and development companies.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10